Follow
Eric Schuur
Eric Schuur
CEO of Hepatx Corporation
Verified email at hepatx.com - Homepage
Title
Cited by
Cited by
Year
Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
R Rodriguez, ER Schuur, HY Lim, GA Henderson, JW Simons, ...
Cancer research 57 (13), 2559-2563, 1997
8011997
Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer (∗)
ER Schuur, GA Henderson, LA Kmetec, JD Miller, HG Lamparski, ...
Journal of Biological Chemistry 271 (12), 7043-7051, 1996
3891996
Ligand-dependent interaction of estrogen receptor-α with members of the forkhead transcription factor family
ER Schuur, AV Loktev, M Sharma, Z Sun, RA Roth, RJ Weigel
Journal of Biological Chemistry 276 (36), 33554-33560, 2001
1792001
Tissue specific viral vectors
DR Henderson, ER Schuur
US Patent 5,698,443, 1997
911997
Tissue specific adenoviral vectors
DR Henderson, ER Schuur
US Patent 6,676,935, 2004
762004
Tissue specific and tumor growth supperssion by adenovirus comprising prostate specific antigen
DR Henderson, ER Schuur
US Patent 5,871,726, 1999
701999
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
AS Little, DR Henderson, ER Schuur, H Lamparski
US Patent 6,254,862, 2001
582001
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
DR Henderson, ER Schuur, DC Yu
US Patent 6,436,394, 2002
562002
Genomic structure of the promoters of the human estrogen receptor-α gene demonstrate changes in chromatin structure induced by AP2γ
ER Schuur, LA McPherson, GP Yang, RJ Weigel
Journal of Biological Chemistry 276 (18), 15519-15526, 2001
542001
Nuclear factor I interferes with transformation induced by nuclear oncogenes
ER Schuur, U Kruse, JS Iacovoni, PK Vogt
Cell Growth and Differentiation-Publication American Association for Cancer …, 1995
501995
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
DR Henderson, ER Schuur, DC Yu
US Patent 6,197,293, 2001
392001
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
DR Henderson, ER Schuur, DC Yu
US Patent 6,197,293, 2001
392001
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
DR Henderson, ER Schuur, DC Yu
US Patent 6,197,293, 2001
392001
Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
DR Henderson, ER Schuur
US Patent 6,916,918, 2005
372005
Monoallelic amplification of estrogen receptor-α expression in breast cancer
ER Schuur, RJ Weigel
Cancer research 60 (10), 2598-2601, 2000
322000
Compositions comprising tissue specific adenoviral vectors
AS Little, HG Lamparski, DR Henderson, ER Schuur
US Patent 7,001,764, 2006
312006
Progress in using circulating tumor cell information to improve metastatic breast cancer therapy
J Alemar, ER Schuur
Journal of oncology 2013, 2013
202013
Selecting postoperative adjuvant systemic therapy for early stage breast cancer: a critical assessment of commercially available gene expression assays
DM Hyams, E Schuur, J Angel Aristizabal, JE Bargallo Rocha, C Cabello, ...
Journal of surgical oncology 115 (6), 647-662, 2017
192017
Chimeras of herpes simplex viral VP16 and jun are oncogenic.
ER Schuur, EJ Parker, PK Vogt
Cell Growth & Differentiation: the Molecular Biology Journal of the American …, 1993
191993
Breast cancer: molecular mechanisms, diagnosis, and treatment
ER Schuur, JP DeAndrade
International Manual of Oncology Practice: (iMOP)-Principles of Medical …, 2015
142015
The system can't perform the operation now. Try again later.
Articles 1–20